Avanos Medical (AVNS) Scheduled to Post Earnings on Wednesday

Avanos Medical (NYSE:AVNSGet Free Report) is scheduled to post its quarterly earnings results before the market opens on Wednesday, October 30th. Analysts expect Avanos Medical to post earnings of $0.36 per share for the quarter. Avanos Medical has set its FY24 guidance at $1.30-1.45 EPS and its FY 2024 guidance at 1.300-1.450 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

Avanos Medical (NYSE:AVNSGet Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.05. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The company had revenue of $171.70 million during the quarter, compared to the consensus estimate of $170.67 million. During the same period last year, the firm earned $0.24 EPS. The company’s revenue for the quarter was up 1.4% on a year-over-year basis. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Avanos Medical Trading Up 0.5 %

Shares of AVNS opened at $22.34 on Monday. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.28 and a quick ratio of 1.49. The firm has a 50 day simple moving average of $23.44 and a 200-day simple moving average of $21.47. Avanos Medical has a 1-year low of $17.24 and a 1-year high of $25.36. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of 131.41 and a beta of 0.91.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Avanos Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday.

Get Our Latest Stock Analysis on AVNS

About Avanos Medical

(Get Free Report)

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

Further Reading

Earnings History for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.